首页>
外国专利>
Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide
Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide
展开▼
机译:包含EGF受体结合肽和细胞毒性肽的选择性抗癌嵌合肽
展开▼
页面导航
摘要
著录项
相似文献
摘要
It is an object of the present invention to provide a substance usable as an anticancer agent or DDS, which has intracellular stability, which is capable of evading side effects from functional disorder with respect to normal cells, or which has instantaneous effect. The inventors developed a novel chimeric peptide targeting cancer cells which overexpress EGFR or the like using a binding peptide such as a peptide sequence binding to EGFR, and a lytic peptide sequence, thereby solving such an object. Particularly, by using a chimeric peptide including an EGF receptor-binding peptide or the like and a cytotoxic peptide, this object was solved.
展开▼